Neoleukin Therapeutics, Inc. | August 17, 2023 | 9,469,838 | 20.0% |
Mereo Biopharma Group plc | August 10, 2023 | 14,604,391 | 2.2% |
Verastem, Inc. | August 10, 2023 | ? | ? |
ACADIA PHARMACEUTICALS INC | May 24, 2023 | 43,084,280 | 26.5% |
INCYTE CORP | March 15, 2023 | 36,280,967 | 16.3% |
Seagen Inc. | March 13, 2023 | 46,985,656 | 25.1% |
Talis Biomedical Corp | March 10, 2023 | 37,569,140 | 66.2% |
Aeglea BioTherapeutics, Inc. | February 14, 2023 | 6,384,013 | 9.9% |
Merus N.V. | February 14, 2023 | ? | ? |
Surrozen, Inc./DE | February 14, 2023 | 833,333 | 2.3% |
Verastem, Inc. | February 14, 2023 | 26,988,898 | 13.5% |
OTONOMY, INC. | February 10, 2023 | ? | ? |
AMARIN CORP PLC\UK | December 12, 2022 | ? | ? |
DBV Technologies S.A. | June 13, 2022 | 23,489,669 | 25.0% |
Kodiak Sciences Inc. | June 06, 2022 | 17,353,846 | 33.4% |
Altimmune, Inc. | February 14, 2022 | 1,941,604 | 4.8% |
Global Blood Therapeutics, Inc. | February 14, 2022 | 3,314,765 | 5.1% |
Invitae Corp | February 14, 2022 | 9,873,488 | 4.4% |
Zymeworks Inc. | February 14, 2022 | 4,977,296 | 10.0% |
Entrada Therapeutics, Inc. | December 16, 2021 | 4,704,419 | 15.1% |
IDERA PHARMACEUTICALS, INC. | April 09, 2021 | 2,066,535 | 4.9% |
InflaRx N.V. | February 16, 2021 | 856,228 | 3.0% |
Krystal Biotech, Inc. | February 16, 2021 | 698,874 | 3.5% |
Kiniksa Pharmaceuticals, Ltd. | July 28, 2020 | 2,880,870 | 9.2% |
Aevi Genomic Medicine, LLC | February 14, 2020 | 564,844 | 0.7% |
CONTRAFECT Corp | February 14, 2020 | 5,553,599 | 3.5% |
CymaBay Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
Principia Biopharma Inc. | February 14, 2020 | 1,808,684 | 5.5% |
BELLICUM PHARMACEUTICALS, INC | January 24, 2020 | 2,491,244 | 5.0% |
AQUINOX PHARMACEUTICALS, INC | August 07, 2019 | 11,359,679 | 48.2% |
GENOMIC HEALTH INC | July 31, 2019 | 9,422,126 | 25.3% |
CATALYST PHARMACEUTICALS, INC. | February 13, 2019 | 2,900,000 | 2.8% |
Clementia Pharmaceuticals Inc. | February 13, 2019 | 3,724,445 | 9.9% |
Foamix Pharmaceuticals Ltd. | February 13, 2019 | 498,189 | 0.9% |
RITTER PHARMACEUTICALS INC | February 13, 2019 | 286,499 | 5.0% |
Tonix Pharmaceuticals Holding Corp. | February 13, 2019 | ? | ? |
Erytech Pharma S.A.Sold out | November 08, 2018 | 0 | 0.0% |
IDERA PHARMACEUTICALS, INC. | March 06, 2018 | 38,956,461 | 18.0% |
Ablynx NV | February 13, 2018 | 4,631,286 | 6.2% |
ACORDA THERAPEUTICS INC | February 13, 2018 | 205,966 | 0.4% |
Arcturus Therapeutics Ltd.Sold out | February 13, 2018 | 0 | 0.0% |
RITTER PHARMACEUTICALS INC | February 13, 2018 | 2,800,000 | 5.7% |
SANGAMO THERAPEUTICS, INC | February 13, 2018 | 2,113,376 | 2.5% |
Tonix Pharmaceuticals Holding Corp. | February 13, 2018 | 699,500 | 8.9% |
Trillium Therapeutics Inc. | February 13, 2018 | 668,313 | 5.0% |
Versartis, Inc. | February 13, 2018 | 1,426,310 | 4.0% |
Achaogen Inc | January 10, 2018 | 122,482 | 0.3% |
DERMA SCIENCES, INC. | March 10, 2017 | ? | ? |
ARROWHEAD PHARMACEUTICALS, INC. | February 14, 2017 | ? | ? |
aTYR PHARMA INC | February 14, 2017 | ? | ? |
Clovis Oncology, Inc. | February 14, 2017 | ? | ? |
IMMUNOGEN INC | February 14, 2017 | 3,015,353 | 3.5% |
PROGENICS PHARMACEUTICALS INC | February 14, 2017 | 3,150,808 | 4.5% |
SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 741,665 | 3.6% |
XENOPORT INCSold out | August 04, 2016 | 0 | 0.0% |
Anacor Pharmaceuticals, Inc. | July 11, 2016 | ? | ? |
ALCOBRA LTD. | February 16, 2016 | 2,336,359 | 8.5% |
ARROWHEAD RESEARCH CORP | February 16, 2016 | 3,680,499 | 5.9% |
Biodel Inc | February 16, 2016 | 871,500 | 1.3% |
LA JOLLA PHARMACEUTICAL CO | February 16, 2016 | 795,191 | 4.2% |
REPROS THERAPEUTICS INC.Sold out | December 10, 2015 | 0 | 0.0% |
SYNAGEVA BIOPHARMA CORPSold out | June 24, 2015 | 0 | 0.0% |
Vanda Pharmaceuticals Inc. | April 10, 2015 | 1,750,230 | 4.2% |
Celsus Therapeutics Plc.Sold out | March 10, 2015 | 0 | 0.0% |
ASSEMBLY BIOSCIENCES, INC.Sold out | February 17, 2015 | 0 | 0.0% |
HALOZYME THERAPEUTICS INC | February 17, 2015 | 2,776,143 | 2.2% |
STEMLINE THERAPEUTICS INC | February 17, 2015 | 338,671 | 2.5% |
TG THERAPEUTICS, INC. | February 17, 2015 | 2,050,313 | 4.7% |
AVANIR PHARMACEUTICALS, INC. | November 10, 2014 | 32,767,078 | 17.0% |
Chelsea Therapeutics International, Ltd. | February 14, 2014 | 5,794,753 | 8.2% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 46,355,851 | 10.0% |
LA JOLLA PHARMACEUTICAL CO | February 14, 2014 | 22,558,069 | 10.0% |
VENTRUS BIOSCIENCES INC | February 14, 2014 | 2,177,840 | 10.0% |
MEI Pharma, Inc. | December 30, 2013 | 746,521 | 3.4% |
MEI Pharma, Inc. | October 31, 2013 | 1,130,317 | 5.1% |
TRANZYME INCSold out | February 11, 2013 | 0 | 0.0% |
YM BIOSCIENCES INCSold out | February 05, 2013 | 0 | 0.0% |
AUXILIUM PHARMACEUTICALS INC | February 04, 2013 | 4,371,129 | 8.9% |
BIODELIVERY SCIENCES INTERNATIONAL INC | February 01, 2013 | 3,164,426 | 10.0% |
INTERMUNE INC | February 01, 2013 | 2,630,588 | 3.3% |
PHARMACYCLICS INC | February 01, 2013 | 11,444,360 | 16.4% |
VIROPHARMA INC | February 01, 2013 | 9,033,265 | 13.7% |
INSMED INC | February 15, 2006 | 3,663,263 | 6.4% |